Canada markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9300-0.0100 (-0.34%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 24.20M
Enterprise Value 13.05M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)14.16
Price/Book (mrq)0.64
Enterprise Value/Revenue 8.92
Enterprise Value/EBITDA -1.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-58.62%
S&P500 52-Week Change 327.86%
52 Week High 37.4000
52 Week Low 32.0800
50-Day Moving Average 33.0232
200-Day Moving Average 33.3600

Share Statistics

Avg Vol (3 month) 311.54k
Avg Vol (10 day) 39.31k
Shares Outstanding 58.26M
Implied Shares Outstanding 68.26M
Float 83.73M
% Held by Insiders 15.77%
% Held by Institutions 155.19%
Shares Short (Mar 15, 2024) 4178.28k
Short Ratio (Mar 15, 2024) 414.05
Short % of Float (Mar 15, 2024) 43.97%
Short % of Shares Outstanding (Mar 15, 2024) 42.16%
Shares Short (prior month Feb 15, 2024) 4182.78k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jul 25, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,195.10%

Management Effectiveness

Return on Assets (ttm)-12.15%
Return on Equity (ttm)-33.56%

Income Statement

Revenue (ttm)1.46M
Revenue Per Share (ttm)0.21
Quarterly Revenue Growth (yoy)540.30%
Gross Profit (ttm)N/A
EBITDA -20.58M
Net Income Avi to Common (ttm)-21.84M
Diluted EPS (ttm)-3.3700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.22M
Total Cash Per Share (mrq)1.72
Total Debt (mrq)3.07M
Total Debt/Equity (mrq)7.24%
Current Ratio (mrq)2.11
Book Value Per Share (mrq)4.55

Cash Flow Statement

Operating Cash Flow (ttm)-28.41M
Levered Free Cash Flow (ttm)-14.61M